logo

For the Inventor, By the Inventor

Bridgewater, NJ, United States of America

Shin S Tseng

This inventor holds 13 USPTO granted patents. Top assignee: American Cyanamid Company. Active years: 1985-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shin S Tseng. Retrieved from https://idiyas.com/inventor/shin-s-tseng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13

% Patents Active = 100.0

Average Co-Inventor Count = 2.9

ph-index = 6

Forward Citations = 89(Granted Patents)


Company Filing History:

goldMedal13 out of 3,580 
 
American Cyanamid Company
 patents

Years Active: 1985-1993

Loading Chart...
13 patents (USPTO):Explore Patents
1. 5219857 - Method of treating cognitive and related neural behavioral problems (1993-06-15),
2. 5169850 - N-(dialkylamino)methylene)-substituted (1992-12-08),
3. 5126340 - 4-[(substituted)alkylcarbonyl]-4,5-dihydro and (1992-06-30),
4. 5059691 - N-((dialkylamino)methylene)-substituted pyrazolo (1991-10-22),
5. 5013737 - 2,4,8-Trisubstituted-3H,6H-1,4,5A,8A-tetraazaacenaph (1991-05-07),
6. 4963553 - 4-[(substituted) alkylcarbonyl]-4,5-dihydro- and (1990-10-16),
7. 4963552 - 1-substitute-1,2-dihydro-4-((substituted)phenyl)imidazo-[1,5-a] (1990-10-16),
8. 4916137 - 5-(Substituted-amino)-8-(phenyl or (1990-04-10),
9. 4904658 - Substituted-6H,8H-pyrimido-[1,2,3-cd]purine-8,10-(9H)-diones and (1990-02-27),
10. 4888345 - 4,8-disubstituted-1,2-dihydro and 1,2,3,4-tetrahydroimidazo-[1,5-a] (1989-12-19),
11. 4847256 - 4,5-dihydro and 4,5,6,7-tetrahydropyrazolo(1,5-A)-pyrimidines (1989-07-11),
12. 4576943 - Pyrazolo[1,5-a]pyrimidines (1986-03-18),
13. 4562189 - Pyrazolylpiperazines (1985-12-31),

Title: Innovations of Shin S. Tseng

Introduction

Shin S. Tseng is a notable inventor based in Bridgewater, NJ, who has made significant contributions to the field of neuropharmacology. With a total of 13 patents to his name, Tseng's work focuses on developing novel compounds aimed at treating cognitive and related neural behavioral problems.

Latest Patents

Among his latest patents, Tseng has developed a method for treating cognitive and related neural behavioral problems through innovative compounds. These compounds include various chemical structures designed to address issues such as anxiety, hypertension, depression, and cognitive defects in warm-blooded animals. Another significant patent involves N-((dialkylamino)methylene)-substituted compounds that serve as neurotropic, anxiolytic, and anti-hypertensive agents in mammals.

Career Highlights

Tseng is currently associated with the American Cyanamid Company, where he continues to advance his research and development efforts. His work has been instrumental in creating therapeutic compositions that have the potential to improve mental health and cognitive function.

Collaborations

Some of his notable coworkers include Joseph William Epstein and John P. Dusza, who have collaborated with Tseng on various projects, contributing to the advancement of their shared goals in neuropharmacology.

Conclusion

Shin S. Tseng's innovative work in the field of neuropharmacology highlights his commitment to addressing critical health issues through scientific research and development. His contributions continue to pave the way for advancements in treatments for cognitive and neural behavioral problems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…